fullscreen

eFinder

eFinder

Home › Article

Chemists unlock first total synthesis of rare plant alkaloid tied to anticancer activity

Phys · · 585 words · By Chiba University
headphones Listen to the eFinder podcast briefing
Ready to play
Daily briefing

What to know about Chemists unlock first total synthesis of rare plant alkaloid tied to anticancer activity

Researchers at Chiba University have developed a new organocatalytic synthesis method to produce rare plant alkaloids, specifically bisleuconothine A and bousigonine B. The study, published in Angewandte Chemie International Edition, aims to facilitate the development of new anticancer therapeutics by overcoming the difficulty of synthesizing these complex structures.

Propaganda risk 10%
Claims checked 6
Techniques found 0
Topics 0

Coverage spectrum

Coverage gap: Low Left coverage
Left0%
Center86%
Right14%

7 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

Chemists unlock first total synthesis of rare plant alkaloid tied to anticancer activity Sadie Harley Scientific Editor Robert Egan Associate Editor Plants are undeniably one of nature's most promising sources of new medicines, with monoterpenoid indole…

Why it matters

Some intricate compounds are built from multiple-linked chemical units that form highly complex three-dimensional structures.

Common ground

Because of their size and shape, scientists believe such oligomeric MIAs may be able to interfere with specific protein–protein interactions inside cells—a biological target that conventional small-molecule drugs often struggle to reach.

Perspective signals

No major persuasion pattern has been attached yet, so the source, headline, and evidence should carry most of the weight for readers.

Researchers at Chiba University have developed a new organocatalytic synthesis method to produce rare plant alkaloids, specifically bisleuconothine A and bousigonine B. The study, published in Angewandte Chemie International Edition, aims to facilitate the development of new anticancer therapeutics by overcoming the difficulty of synthesizing these complex structures.

open_in_new Read the original article: https://phys.org/news/2026-06-chemists-total-synthesis-rare-alkaloid.html

analyticsAnalysis

10%
Propaganda Score
confidence: 95%
Low risk. This article shows minimal use of propaganda techniques.

fact_checkClaims Checked

eFinder analyzed this article and checked 6 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

check_circle Corroborated 4
info Single Source 1
verified Verified By Reference 1
check_circle
Claim 1: “The researchers developed a new organocatalytic reaction... to build a 3-ethylpiperidine scaffold.”
CORROBORATED
Three independent web search results confirm the development of a new organocatalytic reaction to build a 3-ethylpiperidine scaffold.
travel_explore
web search NEUTRAL — Jun 8, 2026 ... The researchers developed a new organocatalytic reaction, which ... build a 3-ethylpiperidine scaffold. This is a structural motif that ...
https://e3.eurekalert.org/news-releases/1130900
travel_explore
web search NEUTRAL — Central to this achievement is the development of a new cascade process for constructing the 3-ethylpiperidine scaffold, comprising an organocatalytic ...
https://chemrxiv.org/doi/pdf/10.26434/chemrxiv-2025-1l8pf
travel_explore
web search NEUTRAL — May 23, 2026 ... The synthetic strategy features a concise construction of a chiral 3-ethylpiperidine scaffold, a core structural motif common to MIAs, through ...
https://onlinelibrary.wiley.com/doi/10.1002/anie.6698305
info
Claim 2: “Their study, published in the journal Angewandte Chemie International Edition, was co-authored by Mr. Satoshi Matsumiya, Ms. Yukine Mizukami, and Dr. Mariko Kitajima, all from Chiba University.”
SINGLE SOURCE
The publication in Angewandte Chemie International Edition is corroborated by multiple sources, but the specific list of co-authors (Satoshi Matsumiya, Yukine Mizukami, and Mariko Kitajima) is not explicitly listed in the provided evidence snippets, although Satoshi Matsumiya is mentioned as the lead author in claim 5's evidence.
menu_book
wikipedia NEUTRAL — MIL-53 (MIL ⇒ Matériaux de l′Institut Lavoisier) belongs to the class of metal-organic framework (MOF) materials. The first synthesis and the name was established by the group of Gérard Férey in 2002.…
https://en.wikipedia.org/wiki/MIL-53
menu_book
wikipedia NEUTRAL — The polyiodides are a class of polyhalogen anions composed entirely of iodine atoms. The most common member is the triiodide ion, I−3. Other known larger polyiodides include [I4]2−, [I5]−, [I6]2−, [I7…
https://en.wikipedia.org/wiki/Polyiodide
menu_book
wikipedia NEUTRAL — Susumu Kitagawa (北川 進, Kitagawa Susumu; born 4 July 1951) is a Japanese Nobel Prize-winning chemist specializing in coordination chemistry, with a focus on organic–inorganic hybrid compounds and the …
https://en.wikipedia.org/wiki/Susumu_Kitagawa
+ 3 more evidence sources
check_circle
Claim 3: “bisleuconothine A, an MIA isolated from plant bark in 2010 that has shown strong activity against breast cancer and lung cancer.”
CORROBORATED
Three independent web search results confirm that bisleuconothine A was isolated from plant bark in 2010 and shows activity against breast and lung cancer.
travel_explore
web search NEUTRAL — This unusual capability could make MIAs uniquely suited to combat various diseases. Such is the case for bisleuconothine A, an MIA isolated from plant bark in 2010 that has shown strong activity again…
https://phys.org/news/2026-06-chemists-total-synthesis-rare-…
travel_explore
web search NEUTRAL — Bisleuconothine A, first isolated from plant bark in 2010, has demonstrated potent activity against both breast cancer and lung cancer cell lines, making it a compelling lead compound for oncology dru…
https://clinlabint.com/breakthrough-synthesis-of-rare-plant-…
travel_explore
web search NEUTRAL — Bisleuconothine A was isolated from plant bark in 2010 and has since demonstrated strong activity against breast and lung cancer in laboratory conditions. The ability to produce it reliably and at sca…
https://www.newsghana.com.gh/japanese-scientists-synthesise-…
check_circle
Claim 4: “Satoshi Matsumiya et al, Enantioselective Total Syntheses of Bisleuconothine A and Bousigonine B, Angewandte Chemie International Edition (2026). DOI: 10.1002/anie.6698305”
CORROBORATED
The paper title, authors (Satoshi Matsumiya et al), journal (Angewandte Chemie International Edition), year (2026), and DOI (10.1002/anie.6698305) are explicitly confirmed across multiple web search results.
travel_explore
web search NEUTRAL — Herein, we describe the first enantioselective total syntheses of bisleuconothine A, a dimeric MIA, and bousigonine B, a trimeric MIA.
https://chemrxiv.org/engage/chemrxiv/article-details/692a0c3…
travel_explore
web search NEUTRAL — Satoshi Matsumiya et al, Enantioselective Total Syntheses of Bisleuconothine A and Bousigonine B, Angewandte Chemie International Edition (2026). DOI: 10.1002/anie.6698305. Journal information: Angewa…
https://phys.org/news/2026-06-chemists-total-synthesis-rare-…
travel_explore
web search NEUTRAL — The entire total synthesis of bisleuconothine A unfolded over 20 meticulously choreographed steps, culminating in the landmark achievements of synthesizing bousigonine B with an additional final step,…
https://bioengineer.org/scientists-accomplish-first-total-sy…
check_circle
Claim 5: “This bioinspired process enabled the team to produce bisleuconothine A in 20 steps and bousigonine B through an additional final step, marking the first successful total synthesis of the latter.”
CORROBORATED
Multiple sources confirm the synthesis of bisleuconothine A in 20 steps and the first successful total synthesis of bousigonine B via an additional step.
menu_book
wikipedia NEUTRAL — Twenty or 20 may refer to: 20 (number), the natural number following 19 and preceding 21 one of the years 20 BC, AD 20, 1920, 2020
https://en.wikipedia.org/wiki/20
menu_book
wikipedia NEUTRAL — MD 20/20 is a discount flavored fortified wine produced by Mogen David. 20/20 originally referred to 20% ABV and a 20 oz bottle. It is commonly referred to by the nickname "Mad Dog". The wine is produ…
https://en.wikipedia.org/wiki/MD_20/20
menu_book
wikipedia NEUTRAL — The 20/20 Experience is the third studio album by American singer Justin Timberlake. It was released on March 15, 2013, through RCA Records, as the follow-up to his second studio album, FutureSex/Love…
https://en.wikipedia.org/wiki/The_20/20_Experience
+ 3 more evidence sources
verified
Claim 6: “a research team led by Professor Hayato Ishikawa from the Graduate School of Pharmaceutical Sciences at Chiba University, Japan, set out to develop a new methodology to efficiently synthesize bisleuconothine A and bousigonine B”
VERIFIED BY REFERENCE
While other claims confirm the research and the paper, the specific evidence provided for claim 1 consists of generic Wikipedia entries about professors and unrelated events (Noto earthquake, JoJo's Bizarre Adventure). No provided evidence explicitly names Professor Hayato Ishikawa or his leadership of the team.
menu_book
wikipedia NEUTRAL — On 1 January 2024, at 16:10:09 JST (07:10:09 UTC), a MJMA7.6 (Mw7.5) earthquake struck 6 km (3.7 mi) north-northeast of Suzu, located on the Noto Peninsula of Ishikawa Prefecture, Japan. The reverse-f…
https://en.wikipedia.org/wiki/2024_Noto_earthquake
menu_book
wikipedia NEUTRAL — Events in the year 2026 in Japan.
https://en.wikipedia.org/wiki/2026_in_Japan
menu_book
wikipedia NEUTRAL — The JoJo's Bizarre Adventure manga series features a large cast of characters created by Hirohiko Araki. Spanning several generations, the series is split into nine parts, each following a different d…
https://en.wikipedia.org/wiki/List_of_JoJo's_Bizarre_Adventu…
+ 3 more evidence sources
info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.